{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:11:07Z","timestamp":1788379867191,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T00:00:00Z","timestamp":1405555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00228-014-1716-8","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T01:27:06Z","timestamp":1405474026000},"page":"1115-1122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactions"],"prefix":"10.1007","volume":"70","author":[{"given":"Ben D.","family":"Snyder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Polasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John O.","family":"Miners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Doogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,17]]},"reference":[{"key":"1716_CR1","volume-title":"Guide to managment of hypertension 2008. Assessing and managing raised blood pressure in adults. Updated 2010","author":"National Heart Foundation","year":"2010","unstructured":"National Heart Foundation (2010) Guide to managment of hypertension 2008. Assessing and managing raised blood pressure in adults. Updated 2010. National Heart Foundation, Sydney"},{"issue":"8736","key":"1716_CR2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(91)90872-M","volume":"337","author":"DG Bailey","year":"1991","unstructured":"Bailey DG et al (1991) Interaction of citrus juices with felodipine and nifedipine. Lancet 337(8736):268\u2013269","journal-title":"Lancet"},{"issue":"4","key":"1716_CR3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0009-9236(97)90191-0","volume":"61","author":"KM Jalava","year":"1997","unstructured":"Jalava KM, Olkkola KT, Neuvonen PJ (1997) Itraconazole greatly increases plasma concentrations and effects of felodipine. Clin Pharmacol Ther 61(4):410\u2013415","journal-title":"Clin Pharmacol Ther"},{"issue":"8609","key":"1716_CR4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(88)90124-9","volume":"2","author":"S Capewell","year":"1988","unstructured":"Capewell S et al (1988) Reduced felodipine bioavailability in patients taking anticonvulsants. Lancet 2(8609):480\u2013482","journal-title":"Lancet"},{"issue":"2","key":"1716_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0090-9556(24)15118-5","volume":"28","author":"B Ma","year":"2000","unstructured":"Ma B, Prueksaritanont T, Lin JH (2000) Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab Dispos 28(2):125\u2013130","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"1716_CR6","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1124\/jpet.104.071803","volume":"311","author":"TM Polasek","year":"2004","unstructured":"Polasek TM et al (2004) Mechanism-based inactivation of human cytochrome P4502C8 by drugs in vitro. J Pharmacol Exp Ther 311(3):996\u20131007","journal-title":"J Pharmacol Exp Ther"},{"key":"1716_CR7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/0091270004270642","volume":"45","author":"RL Walsky","year":"2005","unstructured":"Walsky RL, Gaman EA, Obach RS (2005) Examination of 209 drugs for inhibition of cytochrome P450 2C8. J Clin Pharmacol 45:68\u201378","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"1716_CR8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF00606633","volume":"31","author":"SR Smith","year":"1987","unstructured":"Smith SR et al (1987) Pharmacokinetic interactions between felodipine and metoprolol. Eur J Clin Pharmacol 31(5):575\u2013578","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1716_CR9","first-page":"117","volume":"30","author":"BH Meyer","year":"1992","unstructured":"Meyer BH et al (1992) The effects of felodipine on the pharmacokinetics of diazepam. Int J Clin Pharmacol Ther Toxicol 30(4):117\u2013121","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"Suppl 3","key":"1716_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-198700343-00009","volume":"34","author":"N Rehnqvist","year":"1987","unstructured":"Rehnqvist N et al (1987) Pharmacokinetics of felodipine and effect on digoxin plasma levels in patients with heart failure. Drugs 34(Suppl 3):33\u201342","journal-title":"Drugs"},{"issue":"1","key":"1716_CR11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00007890-200201150-00033","volume":"73","author":"L Butani","year":"2002","unstructured":"Butani L, Berg G, Makker SP (2002) Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient. Transplantation 73(1):159\u2013160","journal-title":"Transplantation"},{"issue":"3","key":"1716_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1517\/17425255.3.3.321","volume":"3","author":"TM Polasek","year":"2007","unstructured":"Polasek TM, Miners JO (2007) In vitro approaches to investigate mechanism-based inactivation of CYP enzymes. Expert Opin Drug Metab Toxicol 3(3):321\u2013329","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1716_CR13","unstructured":"US Food and Drug Administration, Guidance for industry. Drug interaction studies\u2014study design, data analysis, and implications for dosing, and labeling recommendation. 2012: Rockville, MD"},{"key":"1716_CR14","unstructured":"European Medicines Agency, Guideline on the investigation of drug interactions. 2012: London, UK"},{"issue":"4","key":"1716_CR15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0165-022X(92)90014-2","volume":"25","author":"DK Lahiri","year":"1992","unstructured":"Lahiri DK et al (1992) A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested. J Biochem Biophys Methods 25(4):192\u2013203","journal-title":"J Biochem Biophys Methods"},{"issue":"4","key":"1716_CR16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1469-1809.2010.00585.x","volume":"74","author":"GEB Wright","year":"2010","unstructured":"Wright GEB et al (2010) Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population. Ann Hum Genet 74(4):340\u2013350","journal-title":"Ann Hum Genet"},{"issue":"8","key":"1716_CR17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0031-1296226","volume":"61","author":"CL Hsiao","year":"2011","unstructured":"Hsiao CL, Wu YC, Hsu KY (2011) Pharmacokinetics of felodipine extended-release tablets in healthy Taiwanese subjects: a retrospective review. Arzneimittelforschung 61(8):444\u2013451","journal-title":"Arzneimittelforschung"},{"issue":"5","key":"1716_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/clpt.1994.60","volume":"55","author":"KT Olkkola","year":"1994","unstructured":"Olkkola KT, Backman JT, Neuvonen PJ (1994) Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole. Clin Pharmacol Ther 55(5):481\u2013485","journal-title":"Clin Pharmacol Ther"},{"key":"1716_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/bdd.291","volume":"23","author":"BC Kang","year":"2002","unstructured":"Kang BC et al (2002) Influence of fluconazole on the pharmacokientics of omeprazole in healthy volunteers. Biopharm Drug Dispos 23:77\u201381","journal-title":"Biopharm Drug Dispos"},{"issue":"6","key":"1716_CR20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/BF00637602","volume":"35","author":"S Harder","year":"1988","unstructured":"Harder S et al (1988) 4-quinolones inhibit biotransformation of caffeine. Eur J Clin Pharmacol 35(6):651\u2013656","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"1716_CR21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0009-9236(98)90163-1","volume":"63","author":"KM Williamson","year":"1998","unstructured":"Williamson KM et al (1998) Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 63(3):316\u2013323","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1716_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","volume":"104","author":"B Greiner","year":"1999","unstructured":"Greiner B et al (1999) The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Investig 104(2):147\u2013153","journal-title":"J Clin Investig"},{"issue":"5","key":"1716_CR23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.clpt.6100187","volume":"82","author":"JY Ryu","year":"2007","unstructured":"Ryu JY et al (2007) Development of the \u201cInje cocktail\u201d for high-throughput evaluation of five human cytochrome P450 isoforms in vivo. Clin Pharmacol Ther 82(5):531\u2013540","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"1716_CR24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1177\/0091270006292625","volume":"46","author":"B Kirby","year":"2006","unstructured":"Kirby B et al (2006) Simultaneous measurement of in vivo p-glycoprotein and cytochrome P450 3A activities. J Clin Pharmacol 46(11):1313\u20131319","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"1716_CR25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/sj.clpt.6100050","volume":"81","author":"U Fuhr","year":"2007","unstructured":"Fuhr U, Jetter A, Kirchheiner J (2007) Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the \u201ccocktail\u201d approach. Clin Pharmacol Ther 81(2):270\u2013283","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1716_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003088-199631010-00002","volume":"31","author":"T Andersson","year":"1996","unstructured":"Andersson T (1996) Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole. Clin Pharmacokinet 31(1):9\u201328","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"1716_CR27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00003088-200544080-00003","volume":"44","author":"DA Sica","year":"2005","unstructured":"Sica DA, Gehr TW, Ghosh S (2005) Clinical pharmacokinetics of losartan. Clin Pharmacokinet 44(8):797\u2013814","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"1716_CR28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2125.1995.tb05802.x","volume":"40","author":"M Smet De","year":"1995","unstructured":"De Smet M et al (1995) Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers. Br J Clin Pharmacol 40(6):571\u2013575","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1716_CR29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2125.1991.tb03953.x","volume":"32","author":"B Oosterhuis","year":"1991","unstructured":"Oosterhuis B et al (1991) Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose. Br J Clin Pharmacol 32(5):569\u2013572","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1716_CR30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2125.2011.03903.x","volume":"71","author":"T Polasek","year":"2011","unstructured":"Polasek T et al (2011) Perpetrators of pharmacokinetic drug-drug interactions from altered cytochrome P450 activity: a criteria-based assessment. Br J Clin Pharmacol 71(5):727\u2013736","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1716_CR31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF00278576","volume":"38","author":"B Bengtsson-Hasselgren","year":"1990","unstructured":"Bengtsson-Hasselgren B et al (1990) Acute effects of felodipine and nifedipine on hepatic and forearm blood flow in healthy men. Eur J Clin Pharmacol 38(6):529\u2013533","journal-title":"Eur J Clin Pharmacol"},{"key":"1716_CR32","volume-title":"Clinical pharmacokinetics: concepts and applications. 3rd ed","author":"M Rowland","year":"1995","unstructured":"Rowland M, Tozer TN (1995) Clinical pharmacokinetics: concepts and applications. 3rd ed. Williams & Wilkins, Baltimore"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-014-1716-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-014-1716-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-014-1716-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:39:39Z","timestamp":1746304779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-014-1716-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,17]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["1716"],"URL":"https:\/\/doi.org\/10.1007\/s00228-014-1716-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,17]]}}}